Application Sponsors
ANDA 206879 | MACLEODS PHARMS LTD | |
Marketing Status
Application Products
001 | TABLET, EXTENDED RELEASE;ORAL | 400MG | 0 | NEVIRAPINE | NEVIRAPINE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2017-10-06 | STANDARD |
LABELING; Labeling | SUPPL | 6 | AP | 2019-08-14 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
MACLEODS PHARMS LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 206879
[companyName] => MACLEODS PHARMS LTD
[docInserts] => ["",""]
[products] => [{"drugName":"NEVIRAPINE","activeIngredients":"NEVIRAPINE","strength":"400MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"10\/06\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] => [{"actionDate":"08\/14\/2019","submission":"SUPPL-6","supplementCategories":"Labeling-Medication Guide, Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
[actionDate] => 2019-08-14
)
)